Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

/sup 67/Ga citrate scintigraphy

Journal Article · · N.Y. State J. Med.; (United States)
OSTI ID:7124645
One hundred and four gallium-67 citrate scintigrams were performed on patients with a diagnosis of non-Hodgkin's lymphoma. Of the 65 patients who had tumors present at the time of scintigraphy, 60 were diagnosed correctly, 92 percent. The false rate for normal findings was 5 out of 40, 12.5 percent, and the false rate for positive findings was 4 out of 64, 6.3 percent. Overall, the gallium-67 scan detected the tumor in 124 out of 158 anatomic sites involved, 78.5 percent. Tumor in intra-abdominal parenchymal organs and the spleen had generally low sensitivity. No difference in reliability was noted by cell type with 4 out of 40, 10 percent, incorrect scans with nodular lymphoma and 5 out of 64, 8 percent, with diffuse type. Prior radiation and/or chemotherapy did not appear to affect accuracy. Gallium-67 scintigraphic examinations are useful in documenting recurrence and response in non-Hodgkin's lymphoma although its value in initial staging of the disease is limited.
Research Organization:
Roswell Park Memorial Inst., Buffalo
OSTI ID:
7124645
Journal Information:
N.Y. State J. Med.; (United States), Journal Name: N.Y. State J. Med.; (United States) Vol. 76:13; ISSN NYSJA
Country of Publication:
United States
Language:
English